Skip to main content
Livermore
Livermore
ZHEN

Wealthfront Advisers LLC

SEC CIK
0001763921
Latest filing
Aug 7, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
40,124
Value
$3.63M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by Wealthfront Advisers LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202640,124$3.63M<0.1%+3,692+10.1%AddedHolders
Q1 202636,432$2.92M<0.1%+4,116+12.7%AddedHolders
Q4 202532,316$2.75M<0.1%+2,654+8.9%AddedHolders
Q3 202529,662$2.31M<0.1%+2,083+7.6%AddedHolders
Q2 202527,579$2.16M<0.1%+2,566+10.3%AddedHolders
Q1 202525,013$1.81M<0.1%+3,065+14.0%AddedHolders
Q4 202421,948$1.62M<0.1%+5,846+36.3%AddedHolders
Q3 202416,102$1.06M<0.1%−19,359−54.6%ReducedHolders
Q2 202435,461$3.28M<0.1%+10.0%AddedHolders
Q1 202435,460$3.39M<0.1%+321+0.9%AddedHolders
Q4 202335,139$2.68M<0.1%−20,353−36.7%ReducedHolders
Q3 202355,492$3.84M<0.1%+18,145+48.6%AddedHolders
Q2 202337,347$3.52M<0.1%+1,580+4.4%AddedHolders
Q1 202335,767$2.96M<0.1%+3,075+9.4%AddedHolders
Q4 202232,692$2.44M<0.1%−4,253−11.5%ReducedHolders
Q3 202236,945$3.05M<0.1%+1,482+4.2%AddedHolders
Q2 202235,463$3.37M<0.1%−1,232−3.4%ReducedHolders
Q1 202236,695$4.32M<0.1%+6,413+21.2%AddedHolders
Q4 202130,282$3.92M<0.1%+4,004+15.2%AddedHolders
Q3 202126,278$2.98M<0.1%+3,956+17.7%AddedHolders
Q2 202122,322$2.31M<0.1%+2,452+12.3%AddedHolders
Q1 202119,870$1.66M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.